1. Home
  2. PAX vs CAPR Comparison

PAX vs CAPR Comparison

Compare PAX & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patria Investments Limited

PAX

Patria Investments Limited

HOLD

Current Price

$11.17

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

HOLD

Current Price

$19.92

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAX
CAPR
Founded
1988
2005
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
PAX
CAPR
Price
$11.17
$19.92
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$18.00
$44.63
AVG Volume (30 Days)
796.0K
1.7M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
4.81%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.99
N/A
Revenue Next Year
$16.52
$3.31
P/E Ratio
$25.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.56
$4.30
52 Week High
$17.80
$40.37

Technical Indicators

Market Signals
Indicator
PAX
CAPR
Relative Strength Index (RSI) 50.38 30.67
Support Level $11.04 $5.25
Resistance Level $11.38 $30.39
Average True Range (ATR) 0.24 1.33
MACD 0.04 -0.17
Stochastic Oscillator 60.75 21.68

Price Performance

Historical Comparison
PAX
CAPR

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: